0001104659-19-042123.txt : 20190726 0001104659-19-042123.hdr.sgml : 20190726 20190726213016 ACCESSION NUMBER: 0001104659-19-042123 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190724 FILED AS OF DATE: 20190726 DATE AS OF CHANGE: 20190726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOODGRIFT RANDEL WILLIAM CENTRAL INDEX KEY: 0001204554 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 19979217 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 a4.xml 4 X0306 4 2019-07-24 0 0000001800 ABBOTT LABORATORIES ABT 0001204554 WOODGRIFT RANDEL WILLIAM 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 0 1 0 0 Senior Vice President Common shares without par value 2019-07-24 4 M 0 65000 38.40 A 117562 D Common shares without par value 2019-07-24 4 S 0 65000 88.0050 D 52562 D Common shares without par value 2755 I Profit Sharing Trust Option (right to buy) 38.40 2019-07-24 4 M 0 65000 0 D 2019-02-19 2026-02-18 Common shares 65000 18333 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.06, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Balance in the Abbott Laboratories Stock Retirement Trust as of July 24, 2019. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Jessica H. Paik, by power of attorney for Randel W. Woodgrift 2019-07-26